Mass spectrometry / NMR

#Biochemistry #Drug discovery #Drug targets #Mass spectrometry / NMR #Small molecules #Therapeutics

OMass unveils drug discovery pipeline for validated targets 

OMass Therapeutics has shared its pipeline of five novel, differentiated small molecule drug programmes, targeting intractable or inadequately drugged membrane and complex-bound protein targets such as GPCRs (G-protein-coupled receptors), solute carriers and intracellular protein complexes.  The company’s selected programmes focus on validated targets in immunology & rare disease indications with high unmet need. Read More

#News

#Mass spectrometry / NMR

PreOmics launches product for high throughput tissue homogenisation  

PreOmics, developer of tools for mass spectrometry-based protein analyses, has launched BeatBox, its new sample preparation tool for tissues and cells. BeatBox delivers tissue homogenisation and can process up to 96 tissue samples in 10 minutes from 1-5 mg of tissue, with no cross-contamination.    According to… Read More

#News

#Assays #Biotherapeutics #Drug targets #Mass spectrometry / NMR #Webinar

Webinar: How to tackle the challenges of peptide and protein quantification

The importance of biotherapeutics as a class of drugs continues to increase. Indeed, their low toxicity and high specificity justify their investigation as drug candidates. Yet, quantification studies of biotherapies in complex biological matrices can be very challenging. In particular, high background noise and interferences due to endogenous proteins… Read More

#News

#Events #Mass spectrometry / NMR #Technology

MOBILion Systems to showcase mass spectrometry product 

MOBILion Systems will showcase its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, at the 69th Annual American Society for Mass Spectrometry (ASMS) conference.   Taking place from October 31 to November 4, the conference is the first in-person ASMS since 2019 and is being held in Philadelphia. Read More

#News

#Biomedicine #Biopharmaceutical #Drug discovery #Mass spectrometry / NMR

Partnership to accelerate clone selection and process development 

Waters Corporation and Sartorius have partnered to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) data to accelerate the speed and improve the accuracy of biopharmaceutical process development.   The partnership will implement the BioAccord LC-MS System from Waters as a new bioprocess analyser with data connectivity to Sartorius’… Read More

#News

#Collaboration #Drug discovery #Mass spectrometry / NMR #Parkinson's #Research #Schizophrenia #Therapeutics

This week in drug discovery (6-10 September) 

News round-up by DDW’s Megan Thomas for 6 – 10 September  DDW’s Megan Thomas selects five stories which showcase results, data, partnerships and research which offer a promising future for both drug development and eventual treatment of a number of diseases.   New potential therapy for… Read More

#News #Trending News

#Healthcare #Laboratory data #Mass spectrometry / NMR

New mass spectrometry portfolio to advance quantitative analysis  

According to Thermo Fisher Scientific, lab managers, technology leaders and principal scientists in pharmaceutical, food and environmental laboratories can use its new mass specrometry (MS) portfolio and chromatography solutions to accelerate throughput and improve sensitivity to meet rapidly changing regulatory requirements and the fast responses needed to tackle emerging human and… Read More

#News

#AI / data analytics / healthtech / informatics #Biologics #Cell culture #Mass spectrometry / NMR

New data integrations to accelerate bioprocess data insights

908 Devices has announced two data analysis partnerships to integrate with the REBEL, its first at-line fresh and spent cell media analyser for bioprocess labs. With the integration of leading data exploratory tool Sartorius’ SIMCA and Securecell’s Lucullus Process Information Management System (PIMS), users can turn REBEL data into deeper… Read More

#News

#Biopharmaceuticals #Drug delivery #Mass spectrometry / NMR

MOBILion System launches high-resolution Ion Mobility instrument

MOBILion is advancing separation science with the commercialisation of High-Resolution Ion Mobility Mass Spectrometry (HRIM-MS) based on Structures for Lossless Ion Manipulation (SLIM). This product addresses characterisation challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides resolution and reproducibility, faster, simpler method development, and greater instrument uptime. This… Read More

#News

#Biomarkers #Lipids #Mass spectrometry / NMR #Neurodegenerative disorders #SLIM-based High-Resolution Ion Mobility (HRIM)

Enabling advancements in research of biomarkers

Kim Ekroos PhD, Founder & CEO Lipidomics Consulting and Kelly Moser PhD, Lab Operations Manager and Applications Scientist, MOBILion Systems examine advancements in research of biomarkers for early diagnostics and effective treatments for neurodegenerative disorders with High-Resolution Ion Mobility Mass Spectrometry Although the first descriptions and classifications of lipids appeared… Read More

#Exclusive Content

#Mass spectrometry / NMR

Unraveling the phosphoproteome with Trapped Ion Mobility Spectrometry (TIMS)

By Professor Yasushi Ishihama, Laboratory of Molecular and Cellular BioAnalysis, Kyoto University Mass spectrometry (MS) is now widely used in protein biochemistry and proteomics to identify and characterise proteins, with technology constantly evolving to achieve higher depths of coverage, speed, and sensitivity. For example, tandem mass spectrometry (MS/MS) is a… Read More

#Exclusive Content #News

#Immunology / Virology & Vaccines #Mass spectrometry / NMR

It’s all in the technique: how MS provides information on virus structure and function

Andreas Huhmer, Senior Director, Proteomics and Metabolomics, Thermo Fisher Scientific, examines the mass spectrometry techniques providing detailed insight into virus structure and function Our ability to quickly and accurately understand new viruses has been significantly tested in 2020, with the emergence of SARS-CoV-2, the coronavirus causing the COVID-19 pandemic. Since… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development optimisation & technology #Automation / robotics #Business #Cell therapy #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Computational chemistry #Drug development #Drug discovery #Gene therapy #Genomics #High Content Screening #High throughput screening #Immunology / Virology & Vaccines #Lead discovery #Lead optimisation #Mass spectrometry / NMR #Medicinal chemistry #Molecular medicine #Organic chemistry #Pharmokinetics #Precision medicine #RNA #Screening #System biology #Systems biology #Therapeutics #Toxicology

The COVID-19 antiviral race: we’re all in this together

The COVID-19 antiviral race: we're all in this together By Uduak Grace Thomas In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically… Read More

#Covid-19 #Exclusive Content

#Analysis #Business #Lead discovery #Mass spectrometry / NMR #Metabolomics #Protein chemistry / Proteomics #RNA #Therapeutics

Thermo Fisher to showcase new products at Virtual ASMS Event

Thermo Fisher Scientific will provide online programming and virtual exhibits to introduce scientists to a number of new products that build on its leading Orbitrap platform and expand research applications. The company said it will showcase its newest instruments, software and workflow solutions during a company-hosted virtual event, vLC-MS.com,… Read More

#News